Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
LADL: light-activated dynamic looping for endogenous gene expression control.
Kim JH, Rege M, Valeri J, Dunagin MC, Metzger A, Titus KR, Gilgenast TG, Gong W, Beagan JA, Raj A, Phillips-Cremins JE
Nat Methods. 2019 Jun 24. pii: 10.1038/s41592-019-0436-5. doi: 10.1038/s41592-019-0436-5.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
127664LADL AnchorEncodes the LADL Anchor (dCas9-CIBN fusion protein) and puromycin resistance both expressed from the EF1a promoter
127665Empty Anchor ControlEncodes for puromycin resistance expressed from the EF1a promoter
127666Empty Bridge Control Zfp462-Klf4SEEncodes for 4 gRNAs expressed from their individual hU6 promoters. Two gRNAs target the Zfp462 promoter while the other two target the Klf4 stretch enhancer.
127667Empty Target ControlEncodes for the CRY2-HA and mCherry proteins expressed from the EF1a promoter
127668LADL Bridge + Target Zfp462-Klf4SEEncodes for CRY2-HA and mCherry proteins expressed from the EF1a promoter; 2 gRNAs targeting the Zfp462 promoter and 2 gRNAs targeting the Klf4 SE expressed from their individual hU6 promoters
127669LADL Bridge + Promoter Only TargetEncodes for CRY2-HA and mCherry proteins expressed from the EF1a promoter as well as 2 gRNAs targeting the Zfp462 promoter expressed from their individual hU6 promoters
127670S12.1_Empty_BridgeAmpicillin resistant multiplexing backbone without CRY2HA and mCherry
127671S12.2_Bridge + TargetAmpicillin resistant multiplexing backbone with CRY2HA and mCherry

Antibodies from Article